ReNeuron signs exosome collaboration deal with US biopharma
The unnamed US-based company will explore the use of exosomes as a potential delivery vehicle for synthetic oligonucleotides used in gene therapy
Company
ReNeuron Group PLC
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 7 of 15
Archive
Proactive news snapshot: Block Energy, ReNeuron Group, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Science Group takes down the 'for sale' sign
A look at the day's major movers, including Photonstar, Capita, IHG, GVC, Reach and Balfour Beatty
ReNeuron primed for significant clinical progress
The company has two clinical trials underway and is well funded to achieve its immediate ambitions
Investments and investor services
FTSE 100 closes lower as China and Europe worries sends global equities down
Barratt Developments lost 2.69 points at 440.50p , while Persimmon also dropped 2.69% at 1,897p.
Archive
Balfour Beatty investors looking for more reassurance in Friday’s update
The penultimate Friday looks unsurprisingly like being a quiet one, but Balfour Beatty is due to publish a trading update and investors will be looking for more reassurance from the contractor
Archive
All eyes on UK parliament as Brexit deal circus reaches final act
Aside from the crucial Brexit vote, the Week Ahead will also bring UK labour market data, an ECB council meetings and updates from TUI, WPP, Dixons Carphone, Superdry, Ocado and BAT
Archive
Proactive news snapshot: Wishbone Gold, ReNeuron Group, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Sativa Investments shares light up; discoverIE Group shares march higher
A look at some of the winner and losers in UK trading during Thursday's session
ReNeuron’s CTX stem cell platform could be used to fight cancer
ReNeuron thinks CTX could be reprogrammed and used to produce new non-donor-specific cell lines, including NK and T-Cells – the cells that can be modified to attack cancer cells
FTSE 100 closes in red as Wall Street shares lag; Brexit exhaustion
The UK blue-chip benchmark finished down over 27 points at 7,026, while the FTSE 250 closed down over 52 points at 18,961.
Archive
Proactive news snapshot: Pan African Resources, Strategic Minerals, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
ReNeuron to resume discussions with other potential suitors as US pharma group backs out
The unnamed group’s decision not to progress to a definitive licensing agreement had nothing to do with ReNeuron’s technology, the company said
Investments and investor services
FTSE 100 closes higher as trade fears ebb; Kingfisher leads the laggards
The FTSE 100 closed nearly 31 points higher at 7,331, while FTSE 250 added over 42 at 20,500
Water Intelligence shares in positive territory after strong first half performance
A look at some of the top risers and fallers in London on Wednesday
Archive
Proactive news snapshot: Erris Resources, Faron Pharma, Chariot Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron will begin clinical trial shortly; upbeat on potential deals
The cell technology group said the first of a group of 110 patients taking part in PICSE III will be enrolled soon
FTSE 100 closes higher with pound volatile, as tobacco stocks fire up on FDA move
The UK blue chip index rose 34 points to 7,308 around 3.40pm